(HealthDay)—People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic. At least three contenders are vying to become…
Read More
New Zealand tightens travel rules as COVID spreads
New Zealand announced Sunday tighter border restrictions, as new cases of COVID-19 emerged in areas previously free of the coronavirus. “We are introducing the requirement for air travellers aged 17 and over, who are not New Zealand citizens, to be…
Read More
New mouse model for studying the cognitive protection mechanisms in Alzheimer’s
Alzheimer’s is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia. However, researchers have recently discovered a type of people…
Read More
Pelvic floor experts issue new recommendations for magnetic resonance defecography
Magnetic resonance defecography (MRD) has emerged as a powerful, noninvasive imaging technique to evaluate the many possible causes of problems in passing bowel movements. A new set of consensus recommendations for performing and interpreting the results of MRD has been…
Read More
New drug shows promise in treating early-stage breast cancer
Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy, called an oral selective estrogen receptor degrader (SERD), led to clinically…
Read More
New nano particles suppress resistance to cancer immunotherapy
Hokkaido University scientists and colleagues in Japan have found a way that could help some patients overcome resistance to an immunotherapy treatment for cancer. The approach, proven in mice experiments, was reported in the Journal for ImmunoTherapy of Cancer. The…
Read More
New drug slows the regrowth of tumors among some bowel cancer patients
A new drug has shown promise in slowing the regrowth of tumors among some bowel cancer patients, according to new findings of a major trial run by researchers at UCL in collaboration with the Universities of Glasgow, Oxford, Leeds and…
Read More
New findings on B cells may improve vaccine design
Our bodies can fine-tune the immune response to an infection and make it proportional to the threat at hand. New research from Karolinska Institutet in Sweden describes how B lymphocytes, the immune cells that make antibodies, choose between different cell…
Read More
Scientists discover new pathway that prevents bowel cancer treatment from working
Leading scientists at the University of Birmingham have discovered a previously unknown pathway that prevents specific drugs from working in patients with bowel cancer. The research findings pave the way for increasing the number of bowel cancer patients who can…
Read More
New hope for antibody to treat muscular dystrophy
Northwestern Medicine scientists have developed an antibody that they believe can be used to treat muscular dystrophy, findings that were published in Science Translational Medicine. “We believe this can become a therapy for muscular dystrophy, including the many different forms…
Read More